Matinas Biopharma (6LJ0.F) Q4 2025 Earnings

10NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-1
-0.9
-0.79
-0.69

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Matinas Biopharma (6LJ0.F) will report earnings of for Q4 2025 on November 10, 2025.

0 Comments

Share your thoughts